Business registries · firm from USPTO records

AMICUS THERAPEUTICS, INC.

Place
1 Cedar Brook Drive, Cranbury, NJ
Entity type
Corporation
State of organization
DE (as the owner states it in trademark filings)
Patents
93 granted 2005-12-21 to 2022-03-22
Trademarks
34, 13 live
Record
EXACT high confidence: identical full name and state
Form D issuer
AMICUS THERAPEUTICS, INC. EXACT high confidence: identical full name and state
Source
USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place

Patents

PatentTitleGrantedSource
US 12686859Method for selection of high M6P recombinant proteins2026-07-21PTBLXML, file of 2026-07-21
US 12622952Formulations comprising recombinant acid α-glucosidase2026-05-12PTBLXML, file of 2026-05-12
US 12599595Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones2026-04-14PTBLXML, file of 2026-04-14
US 12599594Treatment of Fabry disease in ERT-naïve and ERT-experienced patients2026-04-14PTBLXML, file of 2026-04-14
US 12594268Methods of treating Fabry disease in patients having a mutation in the GLA gene2026-04-07PTBLXML, file of 2026-04-07
US 12552736Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders2026-02-17PTBLXML, file of 2026-02-17
US 12419937High concentration alpha-glucosidase compositions for the treatment of Pompe disease2025-09-23PVGPATDIS, file of 2026-04-10
US 12414985Augmented acid alpha-glucosidase for the treatment of Pompe disease2025-09-16PVGPATDIS, file of 2026-04-10
US 12414944Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene2025-09-16PVGPATDIS, file of 2026-04-10
US D1087752Drug package2025-08-12PVGPATDIS, file of 2026-04-10
US D1082532Drug package2025-07-08PVGPATDIS, file of 2026-04-10
US 12280042Methods of treating fabry patients having renal impairment2025-04-22PVGPATDIS, file of 2026-04-10
US 12275703Highly purified batches of pharmaceutical grade migalastat and methods of producing the same2025-04-15PVGPATDIS, file of 2026-04-10
US 12246062Recombinant human acid alpha-glucosidase2025-03-11PVGPATDIS, file of 2026-04-10
US 12109205Methods of treating Fabry patients having renal impairment2024-10-08PVGPATDIS, file of 2026-04-10
US 12070453Treatment of Fabry disease in ERT-naïve and ERT-experienced patients2024-08-27PVGPATDIS, file of 2026-04-10
US 12064485Disulfide bond stabilized polypeptide compositions and methods of use2024-08-20PVGPATDIS, file of 2026-04-10
US 12042490Methods of treating Fabry patients having renal impairment2024-07-23PVGPATDIS, file of 2026-04-10
US 12042489Methods of treating Fabry patients having renal impairment2024-07-23PVGPATDIS, file of 2026-04-10
US 12042488Methods of treating Fabry patients having renal impairment2024-07-23PVGPATDIS, file of 2026-04-10
US 11903938Methods of treating Fabry patients having renal impairment2024-02-20PVGPATDIS, file of 2026-04-10
US 11833164Methods of treating Fabry disease in patients having a mutation in the GLA gene2023-12-05PVGPATDIS, file of 2026-04-10
US 11826360Methods of treating Fabry patients having renal impairment2023-11-28PVGPATDIS, file of 2026-04-10
US 11813255Methods of treating Fabry patients having renal impairment2023-11-14PVGPATDIS, file of 2026-04-10
US 11786516Methods of treating Fabry patients having renal impairment2023-10-17PVGPATDIS, file of 2026-04-10

The newest 25 of 93. All patents of this assignee

Trademarks

MarkSerialFiledStatusClassesSource
EUHENZY889302142020-05-22Abandoned005TRCFECO2, file of 2024-03-27
OPFOLDA889302112020-05-22Abandoned005TRCFECO2, file of 2024-03-27
ZYMFOLDA889302092020-05-22Abandoned005TRCFECO2, file of 2024-03-27
RENJOZY889302052020-05-22Abandoned005TRCFECO2, file of 2024-03-27
UPOMVI889301982020-05-22Abandoned005TRCFECO2, file of 2024-03-27
POMBILITI889301942020-05-22Abandoned005TRCFECO2, file of 2024-03-27
(design)888399982020-03-19Registered044TRTDXFAP, file of 2026-04-08
CRADLE OF CURES887124212019-12-02Registered044TRTDXFAP, file of 2026-04-30
MYDAY885248062019-07-19Registered009TRTDXFAP, file of 2026-04-25
OUR GOOD STUFF876746382017-11-07Registered016TRTYRAP, file of 2026-04-03
HEALING BEYOND DISEASE876746132017-11-07Registered035, 044TRTYRAP, file of 2026-04-03
(design)875376042017-07-21Abandoned005TRCFECO2, file of 2024-03-27
(design)875375992017-07-21Abandoned005TRCFECO2, file of 2024-03-27
CHART874996812017-06-21Abandoned005TRCFECO2, file of 2024-03-27
CHART874996532017-06-21Abandoned005TRCFECO2, file of 2024-03-27
AMICUS ASSIST869407562016-03-15Registered036, 044TRTDXFAP, file of 2026-03-31
(design)868394782015-12-04Registered005TRTYRAP, file of 2026-04-03
GALAFOLD868394732015-12-04Registered005TRTYRAP, file of 2026-04-03
(design)868394652015-12-04Registered005TRTYRAP, file of 2026-04-03
GALAFOLD868394572015-12-04Registered005TRTYRAP, file of 2026-04-03
GALAFOLD864654012014-11-26Registered005TRTYRAP, file of 2026-04-03
PLICERA863336732014-07-10Abandoned005TRCFECO2, file of 2024-03-27
CHART861398322013-12-10Abandoned005TRCFECO2, file of 2024-03-27
CHART861398152013-12-10Abandoned005TRCFECO2, file of 2024-03-27
CHART860303692013-08-06Abandoned005TRCFECO2, file of 2024-03-27

The newest 25 of 34. All marks of this owner

Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.

Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.